Topic

Washington

A collection of 489 issues

UnitedHealthcare Coverage for Oxbryta (Voxelotor) in Washington: 2024 FDA Withdrawal and Alternative Options

Answer Box: Oxbryta Coverage Status Oxbryta (voxelotor) is no longer available and cannot be covered by UnitedHealthcare or any insurer. Pfizer voluntarily withdrew the drug in September 2024 following FDA safety review. Your fastest path forward: Work with your hematologist to transition to FDA-approved alternatives like hydroxyurea, L-glutamine, or crizanlizumab.
5 min read

If Darzalex Isn't Approved by UnitedHealthcare in Washington: Formulary Alternatives & Exception Paths

Answer Box: When Darzalex Isn't Your First Option If UnitedHealthcare denies Darzalex (daratumumab) in Washington, you have proven alternatives and exception paths. Fastest approach: Try formulary alternatives like Sarclisa (isatuximab) or proteasome inhibitors first, document response/failure thoroughly, then request a Darzalex exception with clinical evidence. Start today:
6 min read

UnitedHealthcare's Coverage Criteria for Synagis (Palivizumab) in Washington: What Counts as "Medically Necessary"?

Answer Box: Getting Synagis Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for all Synagis (palivizumab) prescriptions with strict high-risk pediatric criteria. You must prove why Beyfortus (nirsevimab) isn't appropriate first. Fast track: Submit PA through the UnitedHealthcare Provider Portal with complete cardiology/pulmonology notes, birth certificate,
5 min read